Anti-viral guanosine-rich oligonucleotides
申请(专利)号： AU19940069427
专利号： AU700196B2 主分类号： A61K31/70 申请权利人： TRIPLEX
PHARMACEUTICAL CORPORATION; BAYLOR
COLLEGE OF MEDICINE
申请日： 1994-04-25 公开公告日： 1998-12-24
分类号： A61K31/70;
C07H21/02
发明设计人： ROBERT F RANDO;
SUSAN
FENNEWALD; JOSEPH G ZENDEGUI; JOSHUA O OJWANG;
MICHAEL E HOGAN 申请国代码： AU
优先权： 19930423 US
5302793; 19931028 US 14570493; 19940425 US 9404529
摘 要 附 图：
公开国代码： AU 优先权国家： US
摘 要：
A method and compositions for treating viral infection in vitro and in vivo using a guanosine-rich oligonucleotides. The
oligonucleotides are composed of at least about 50% guanosine nucleotides. Also provided are guanosine-rich
oligonucleotides and methods for treating viral infections in humans, and a method for designing guanosine-rich
oligonucleotides having anti-viral activity. 主权项：
2. The method of claim 1, wherein said oligonucleotide is capped at the 3' terminus with a modifier
权 利 要 求 说 明 书
【Anti-viral guanosine-rich oligonucleotides】的权利说明书内容是......请下载后查看
说 明 书
【Anti-viral guanosine-rich oligonucleotides】的说明书内容是......请下载后查看
Anti-viral guanosine-rich oligonucleotides
